Medical Services to Deliver Dengue Fever Rapid Test Kits to Middle East
March 16 2006 - 1:39PM
PR Newswire (US)
EDMONTON, Alberta, March 16 /PRNewswire-FirstCall/ -- Medical
Services International Inc., (OTC:MSITF) wishes to announce that
the Company has been asked to supply the VScan Dengue Fever Kit to
several countries in the Middle East. Over the last month there has
been a serious outbreak of Dengue Fever in the Middle East and it
is very difficult to get testing done in standard labs. Further,
the delay of results is up to three weeks even if there is space at
the lab. Dengue Fever is transmitted by mosquitos. In order to
control the out break on Dengue Fever there must be access to fast
accurate testing. The Vscan Dengue Fever Kit gives fast accurate
testing. The VScan Dengue Fever kits is a dual flow kit that
detects both IgM and IgG individually and at the same time. Any
other Dengue kit currently on the market only detects IgG and as
such is not as sensitive and accurate as the VScan test kit. The
key to treating and controlling outbreaks of Dengue Fever is fast,
accurate testing. The VScan Dengue Fever test kit is an accurate
(greater than 99% of the time) easy to use test kit that gives
results in under 15 minutes. The treatment for certain kinds of
Dengue Fever is fluid replacement therapy that is only effective if
administered quickly after infection. Based on conversations with
our distributor in the area, there will be requirements for at
least 500,000 Dengue Test kits this year in the Middle East. The
first Dengue Fever kits to the Middle East have already been
shipped. About VScan The VScan rapid test kit is a single use,
disposable, accurate, cost effective, easy to use test for the
screening of HIV1&2, Hepatitis B&C, Tuberculosis (TB),
Dengue Fever, West Nile, Syphilis, Malaria and Prostate Cancer. The
kits cannot be sold in Canada. Medical Services International Inc.
trades in the Unites States on the NQB Pinksheets under the symbol
"MSITF". For further information, please contact Robert Talbot at
(780) 430 6363 or http://www.medicalservicesintl.com/ or
http://www.minerva-biotech.com/ . NOTE: Certain statements in this
press release are "forward-looking statements" within the meaning
of the Private Securities Act of 1995. Such statements involve
known and unknown risks, uncertainties and other factors that may
cause results to differ materially. Such risks, uncertainties and
other factors include but are not limited to new economic
conditions, risk in product development, market acceptance of new
products and continuing product demand, level of competition and
other factors described in Company reports and other filings with
regulatory bodies. Medical Services International Inc. DATASOURCE:
Medical Services International Inc. CONTACT: Robert Talbot of
Medical Services International Inc., +1-780-430-6363 Web site:
http://www.medicalservicesintl.com/ http://www.minerva-biotech.com/
Copyright